Wave Life Sciences Ltd. Ordinary Shares

WVE Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
WVE Income Statement
WVE Balance Sheet
WVE Cash Flow
Congress Trading

Recent trades of WVE by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
WVE Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
WVE Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
WVE Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by WVE's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $15,000 Jan 17, 2023 Issue: Health Issues
  • $15,000 Oct 17, 2022 Issue: Health Issues
  • $15,000 Jul 20, 2022 Issue: Health Issues
  • $15,000 Apr 20, 2022 Issue: Health Issues
  • $15,000 Jan 31, 2022 Issue: Health Issues
  • $15,000 Nov 02, 2021 Issue: Health Issues
  • $15,000 Jul 20, 2021 Issue: Health Issues
  • $15,000 Apr 23, 2021 Issue: Health Issues
  • $15,000 Jan 22, 2021 Issue: Health Issues
  • $15,000 Oct 19, 2020 Issue: Health Issues
  • $15,000 Jul 28, 2020 Issue: Health Issues
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Compositions and methods for phosphoramidite and oligonucleotide synthesis Jan. 16, 2024
  • Patent Title: Oligonucleotide compositions and methods thereof Aug. 29, 2023
  • Patent Title: Compounds, compositions and methods for synthesis Aug. 08, 2023
  • Patent Title: Chiral control May. 09, 2023
  • Patent Title: Oligonucleotide compositions and methods thereof Apr. 25, 2023
  • Patent Title: Technologies for oligonucleotide preparation Mar. 21, 2023
  • Patent Title: Oligonucleotide compositions and methods of use thereof Mar. 14, 2023
  • Patent Title: Oligonucleotide compositions and methods of use thereof Mar. 07, 2023
  • Patent Title: Oligonucleotide compositions and methods thereof Mar. 07, 2023
  • Patent Title: Compositions and methods for phosphoramidite and oligonucleotide synthesis Aug. 09, 2022
  • Patent Title: Asymmetric auxiliary group Oct. 05, 2021
  • Patent Title: Oligonucleotides, compositions and methods thereof May. 25, 2021
  • Patent Title: Chiral design Oct. 27, 2020
  • Patent Title: Oligonucleotide compositions and methods thereof Jul. 28, 2020
  • Patent Title: Asymmetric auxiliary group Jun. 30, 2020
  • Patent Title: Chiral control Mar. 17, 2020
  • Patent Title: Oligonucleotide compositions and methods thereof Nov. 19, 2019
  • Patent Title: Oligonucleotide compositions and methods thereof Oct. 22, 2019
  • Patent Title: Chiral auxiliaries Oct. 01, 2019
  • Patent Title: Method for the synthesis of phosphorus atom modified nucleic acids Jun. 25, 2019
  • Patent Title: Nucleic acid prodrugs and methods of use thereof Jun. 04, 2019
  • Patent Title: Methods for the synthesis of functionalized nucleic acids May. 07, 2019
  • Patent Title: Asymmetric auxiliary group Jan. 01, 2019
  • Patent Title: Chiral design Dec. 25, 2018
  • Patent Title: Chiral control May. 29, 2018
  • Patent Title: Chiral control Feb. 06, 2018
  • Patent Title: Nucleic acid prodrugs and methods of use thereof Aug. 29, 2017
  • Patent Title: Methods for the synthesis of functionalized nucleic acids Mar. 28, 2017
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard
Government Contracts

Estimated quarterly amount awarded from public contracts

Quiver Logo

No recent Government Contracts for this ticker

Government Contracts Dashboard
WallStreetBets

Number of mentions of WVE in WallStreetBets Daily Discussion

WVE News

Recent insights relating to WVE

CNBC Recommendations

Recent picks made for WVE stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in WVE

WVE Top Shareholders
Shareholder
Shares Held
WVE Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

WVE Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view WVE Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top